M.A. Hallman

1.0k total citations
56 papers, 667 citations indexed

About

M.A. Hallman is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M.A. Hallman has authored 56 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 25 papers in Radiation and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M.A. Hallman's work include Prostate Cancer Diagnosis and Treatment (27 papers), Advanced Radiotherapy Techniques (25 papers) and Prostate Cancer Treatment and Research (24 papers). M.A. Hallman is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (27 papers), Advanced Radiotherapy Techniques (25 papers) and Prostate Cancer Treatment and Research (24 papers). M.A. Hallman collaborates with scholars based in United States, Canada and Italy. M.A. Hallman's co-authors include Talha Shaikh, Stephanie Yoon, Nicholas G. Zaorsky, Mark L. Sobczak, S.B. Hayes, Eric M. Horwitz, Shougang Zhuang, Marc C. Smaldone, Rick G. Schnellmann and Robert G. Uzzo and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Clinical Nutrition and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

M.A. Hallman

49 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.A. Hallman United States 14 393 183 149 134 109 56 667
Lorenzo Tosco Belgium 14 629 1.6× 109 0.6× 154 1.0× 38 0.3× 143 1.3× 42 751
Daniel Y. Song United States 13 518 1.3× 195 1.1× 58 0.4× 153 1.1× 105 1.0× 86 729
Jeffrey Karnes United States 11 826 2.1× 137 0.7× 61 0.4× 55 0.4× 218 2.0× 33 969
Renuka Malik United States 15 694 1.8× 234 1.3× 77 0.5× 322 2.4× 253 2.3× 60 1.0k
Jean‐Claude M. Rwigema United States 19 482 1.2× 198 1.1× 88 0.6× 251 1.9× 231 2.1× 55 860
Boris Bahoric Canada 16 454 1.2× 164 0.9× 50 0.3× 131 1.0× 153 1.4× 75 770
Vanessa Di Cataldo Italy 14 296 0.8× 170 0.9× 35 0.2× 170 1.3× 119 1.1× 61 579
A. De La Taille France 13 533 1.4× 95 0.5× 222 1.5× 34 0.3× 142 1.3× 56 724
Theo de Reijke Netherlands 15 840 2.1× 101 0.6× 230 1.5× 51 0.4× 127 1.2× 31 1.1k
Mingwei Ma China 10 255 0.6× 286 1.6× 120 0.8× 44 0.3× 69 0.6× 47 574

Countries citing papers authored by M.A. Hallman

Since Specialization
Citations

This map shows the geographic impact of M.A. Hallman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Hallman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Hallman more than expected).

Fields of papers citing papers by M.A. Hallman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Hallman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Hallman. The network helps show where M.A. Hallman may publish in the future.

Co-authorship network of co-authors of M.A. Hallman

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Hallman. A scholar is included among the top collaborators of M.A. Hallman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Hallman. M.A. Hallman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lukez, Alexander, Zhang Li, Eric M. Horwitz, et al.. (2025). Computed Tomography-Guided Online Adaptive Stereotactic Body Radiation Therapy for Liver Tumors: A Retrospective Study. International Journal of Radiation Oncology*Biology*Physics. 122(3). 659–667. 1 indexed citations
2.
Ghatalia, Pooja, Eric A. Ross, Matthew R. Zibelman, et al.. (2025). A phase 2 trial of risk enabled therapy after neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer (RETAIN-2).. Journal of Clinical Oncology. 43(5_suppl). 815–815. 2 indexed citations
3.
Ruth, Karen, M.A. Hallman, David Y.T. Chen, et al.. (2024). Comparison of perioperative and subacute postoperative complications between LDR and HDR monotherapy brachytherapy for prostate cancer. Brachytherapy. 23(5). 559–568. 2 indexed citations
4.
Geynisman, Daniel M., Philip H. Abbosh, Eric A. Ross, et al.. (2024). Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1). Journal of Clinical Oncology. 43(9). 1113–1122. 9 indexed citations
5.
Sandler, Howard M., Priti Lal, Michael D. Feldman, et al.. (2024). Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens. The Journal of Pathology. 265(2). 146–157. 1 indexed citations
8.
Deng, Mengying, Elizabeth Handorf, Jonathan J. Paly, et al.. (2021). Early Prostate-Specific Antigen Kinetics for Low- and Intermediate-Risk Prostate Cancer Treated With Definitive Radiation Therapy. Practical Radiation Oncology. 12(1). 60–67.
10.
Yoon, Stephanie, Talha Shaikh, & M.A. Hallman. (2017). Therapeutic management options for stage III non-small cell lung cancer. World Journal of Clinical Oncology. 8(1). 1–1. 172 indexed citations
11.
Lee, Charles T., Yanqun Dong, Tianyu Li, et al.. (2017). Local Control and Toxicity of External Beam Reirradiation With a Pulsed Low-dose-rate Technique. International Journal of Radiation Oncology*Biology*Physics. 100(4). 959–964. 9 indexed citations
12.
Johnson, Skyler B., Pamela R. Soulos, Timothy D. Shafman, et al.. (2016). Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). E242–E242. 1 indexed citations
13.
Shaikh, Talha, Karen Ruth, M.A. Hallman, et al.. (2016). The impact of trainee involvement on outcomes in low-dose-rate brachytherapy for prostate cancer. Brachytherapy. 15(2). 156–162. 3 indexed citations
14.
Zaorsky, Nicholas G., Jeff M. Martin, Karen Ruth, et al.. (2016). Patient reported outcomes among treatment modalities for prostate cancer.. PubMed. 23(6). 8535–8545. 16 indexed citations
15.
Shaikh, Talha, Thomas M. Churilla, Colin T. Murphy, et al.. (2016). Absence of Pathological Proof of Cancer Associated with Improved Outcomes in Early-Stage Lung Cancer. Journal of Thoracic Oncology. 11(7). 1112–1120. 14 indexed citations
16.
Zaorsky, Nicholas G., Thomas M. Churilla, Karen Ruth, et al.. (2016). Men’s health supplement use and outcomes in men receiving definitive intensity-modulated radiation therapy for localized prostate cancer. American Journal of Clinical Nutrition. 104(6). 1583–1593. 2 indexed citations
17.
Ruth, K., T.M. Churilla, Rosalia Viterbo, et al.. (2015). The Need for Androgen Deprivation Therapy in Patients With Intermediate-Risk Prostate Cancer Treated With Dose-Escalated External Beam Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 93(3). E237–E238. 3 indexed citations
18.
Shaikh, Talha, Elizabeth A. Handorf, Colin T. Murphy, et al.. (2015). Contemporary Trends in the Utilization of Radiotherapy in Patients With Renal Cell Carcinoma. Urology. 86(6). 1165–1173. 8 indexed citations
19.
Knoepp, Stewart M., Yuhuan Xie, Zhihong Zhang, et al.. (2008). Effects of Active and Inactive Phospholipase D2 on Signal Transduction, Adhesion, Migration, Invasion, and Metastasis in EL4 Lymphoma Cells. Molecular Pharmacology. 74(3). 574–584. 69 indexed citations
20.
Knoepp, Stewart M., et al.. (2006). RasGRP1 Confers the Phorbol Ester-Sensitive Phenotype to EL4 Lymphoma Cells. Molecular Pharmacology. 71(1). 314–322. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026